TNF and inflammatory bowel disease: TNF in particular plays a central role in the pathogenesis of IBD (Billmeier et al., 2016) as shown by the clinical efficacy of anti-TNF medications such as infliximab (IFX) or adalimumab (ADA)-mainstay therapies for both CD and UC.